Aggressive surgical therapy for Klatskin tumors

Area of Science:

• Hepatobiliary Surgery
• Surgical Oncology
• Gastroenterology

Background:

• Cholangiocarcinoma of the hepatic duct bifurcation, also known as Klatskin tumor, presents unique surgical challenges.
• Optimal surgical management for Klatskin tumors remains debated, balancing radical resection with patient morbidity.

Purpose of the Study:

• To evaluate the outcomes of limited hepatic resection with Roux-en-Y biliary-enteric anastomosis and stenting for Klatskin tumors.
• To assess the efficacy of an aggressive surgical approach for both curative and palliative treatment of Klatskin tumors.

Main Methods:

• Retrospective review of 31 patients undergoing limited hepatic resection and Roux-en-Y reconstruction between 1981 and 1991.
• Procedures involved wide tumor excision and bile duct resection at the liver hilum, avoiding major hepatic resection unless vascular invasion was present.

Main Results:

• Overall mean postoperative survival was 17 months.
• Patients undergoing curative surgery had a mean survival of 21 months, versus 12 months for palliative cases.
• Major complications occurred in 16% of patients, with a 6% perioperative mortality rate.

Conclusions:

• Limited hepatic resection with Roux-en-Y reconstruction is a viable approach for Klatskin tumors.
• An aggressive surgical strategy, even for palliation, can improve survival outcomes in selected patients.